Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by TM4SF1 is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Additionally we are shipping TM4SF1 Proteins (3) and many more products for this protein.
Showing 10 out of 62 products:
Human Polyclonal TM4SF1 Primary Antibody for EIA, IHC (p) - ABIN955237
Gordon, Dong, Yeap, Richards, Glickman, Edenfield, Mani, Colquitt, Maulik, Van Oss, Sugarbaker, Bueno: Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma. in Journal of the National Cancer Institute 2009
Show all 4 references for ABIN955237
Human Polyclonal TM4SF1 Primary Antibody for IHC (p), WB - ABIN656640
Wang, Bao, Zhang, Cui, Shi: Transmembrane-4-L-six-family-1, a potential predictor for poor prognosis, overexpressed in human glioma. in Neuroreport 2015
Human Polyclonal TM4SF1 Primary Antibody for EIA, WB - ABIN783425
Marken, Schieven, Hellström, Hellström, Aruffo: Cloning and expression of the tumor-associated antigen L6. in Proceedings of the National Academy of Sciences of the United States of America 1992
The findings suggest that TM4SF1 is a surface membrane antigen that is highly expressed in pancreatic cancer cells and increases the chemoresistance to gemcitabine. TM4SF1 may be a promising target to overcome the chemoresistance of pancreatic cancer.
TM4SF1 overexpression significantly contributed MDA-MB-231 cell migration but decreased apoptotic cells
Study shows that TM4SF1 expression is associated with better prognosis in pancreatic cancer. Its loss contributes to the invasion and migration of pancreatic cancer cells.
We found that miR (show MLXIP Antibodies)-203 was significantly downregulated in OSF (show OSTF1 Antibodies) tissues compared to that in normal buccal mucosa tissues, and that miR (show MLXIP Antibodies)-203 negatively regulated secreted SFRP4 (show SFRP4 Antibodies) and positively regulated TM4SF1
These findings validate TM4SF1 as an attractive candidate for cancer therapy with antibody-bound toxins that have the capacity to react with either cytoplasmic or nuclear targets in tumor cells or tumor-associated vascular endothelium.
TM4SF1 is a small plasma membrane glycoprotein (show CD86 Antibodies) that regulates cell motility and proliferation, and possibly a new vascular therapeutic target in cancer
High TM4SF1 expression is associated with pancreatic cancer.
TM4SF1, like genuine tetraspanins, serves as a molecular organizer that interacts with membrane and cytoskeleton-associated proteins and uniquely initiates the formation of nanopodia and facilitates cell polarization and migration.
We provide evidence that ARHGDIA (show ARHGDIA Antibodies), COBLL1, and TM4SF1 are negative regulators of apoptosis in cultured tumor cells.
Inhibition of cell migration after targeted knockdown of TM4SF1 protein expression suggests its contribution to prostate cancer cell metastasis.
The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface antigen and is highly expressed in different carcinomas.
transmembrane 4 L six family member 1
, transmembrane 4 superfamily member 1
, transmembrane 4 L6 family member 1
, membrane component chromosome 3 surface marker 1
, membrane component, chromosome 3, surface marker 1
, tumor-associated antigen L6
, Tumor-associated antigen L6 homolog
, 12A8 target antigen
, L6 antigen
, membrane component chromosome 3 surface marker 1 homolog
, membrane component, surface marker 1